Search company, investor...
Beckman Coulter company logo

Beckman Coulter

Founded Year



Grant | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+50 points in the past 30 days

About Beckman Coulter

Beckman Coulter develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. The company's diagnostic systems are found in hospitals and other critical care settings around the world, producing information used by physicians to diagnose diseases, make treatment decisions, and monitor patients. Scientists use the company's life science research instruments to study complex, biological problems, including causes of disease and potential new therapies or drugs. Beckman Coulter operates as a subsidiary of Danaher. The company was founded in 1935 and is based in Brea, California.

Headquarters Location

250 South Kraemer Boulevard

Brea, California, 92821,

United States

+1 714 993 5321

Missing: Beckman Coulter's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Beckman Coulter's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Beckman Coulter

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Beckman Coulter is included in 2 Expert Collections, including Medical Devices.


Medical Devices

3,805 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos


Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Beckman Coulter Patents

Beckman Coulter has filed 440 patents.

The 3 most popular patent topics include:

  • Laboratory equipment
  • Molecular biology
  • Blood tests
patents chart

Application Date

Grant Date


Related Topics




Dietary supplements, Food additives, Blood tests, Molecular biology, Electron microscopy


Application Date


Grant Date



Related Topics

Dietary supplements, Food additives, Blood tests, Molecular biology, Electron microscopy



Latest Beckman Coulter News

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

Jan 20, 2023

Search jobs 20-Jan-2023 Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices Company Announces Initiation of Second Phase of Expansion Project     LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub. The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport. As part of the expansion, the company also projects the creation of 85 new high-paying Loveland  jobs in the coming years in fields including science research, engineering, and project management. The company currently employs more than 140 full-time associates in Loveland. “The relentless pursuit of innovation is what drives our business and our associates each and every day,” said Suzanne Foster, President of Beckman Coulter Life Sciences. “We continue to be impressed by the talent community that exists in greater Loveland, which has fueled our growth in Colorado since we came here in 2018 with nearly three-dozen associates. Our instruments are on the frontlines of major global research facilities, providing them with valuable automation solutions to accelerate answers for that next big breakthrough moment. We’re thrilled to be expanding in Loveland, where our growing team will play a key role in that evolution.”   The new state-of-the-art complex includes 56,000 square feet of office space featuring collaboration zones, breakout rooms, technology centers, gathering spaces, and a gym for associates. The facility also includes a new innovative Customer Engagement Center which allows customers an inside look at the solutions available from Beckman Coulter Life Sciences, along with how they are created and can be tailored to meet individual and specialized laboratory needs. The company also formally announces the initiation of its second phase of expansion in Loveland, with a 37,000-square-foot manufacturing operation to be attached to the office site. Ground is set to be broken by the second quarter of 2023, with an anticipated completion date in early 2024. “I am excited to congratulate Beckman Coulter Life Sciences on their official opening today in Loveland, creating 85 good-paying jobs in Northern Colorado,” said Colorado Governor Jared Polis. “As Colorado continues to position itself as a leader in advanced industries like bioscience, I am thrilled to see more companies choosing to move and expand in our state.”   Beckman Coulter Life Sciences is also giving back to the greater Loveland community with a donation to Restoring Colorado’s Forests, which will ensure the planting of 140 trees – one for each current associate – to replace those lost due to the recent devastating wildfires and other environmental damage. Beckman Coulter Life Sciences was assisted by CBRE, Etkin Johnson Real Estate Partners, and the Colorado Office of Economic Development and International Trade.

Beckman Coulter Frequently Asked Questions (FAQ)

  • When was Beckman Coulter founded?

    Beckman Coulter was founded in 1935.

  • Where is Beckman Coulter's headquarters?

    Beckman Coulter's headquarters is located at 250 South Kraemer Boulevard, Brea.

  • What is Beckman Coulter's latest funding round?

    Beckman Coulter's latest funding round is Grant.

  • Who are the investors of Beckman Coulter?

    Investors of Beckman Coulter include Biomedical Advanced Research and Development Authority, Danaher and Fletcher Spaght Ventures.

  • Who are Beckman Coulter's competitors?

    Competitors of Beckman Coulter include ThinkCyte and 2 more.

Compare Beckman Coulter to Competitors

Inflammatix Logo

Inflammatix is a molecular diagnostics company that develops rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acute bacterial, viral infections, and sepsis.

Visby Medical Logo
Visby Medical

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.

Torus Biosystems Logo
Torus Biosystems

Torus Biosystems develops a syndromic diagnostic device designed for use in testing DNA for scientific and medical research purposes. Its Torus Synestia System provides seamless, comprehensive, sample-to-insight test results for major infectious diseases in a faster format than conventional methods, helping for better patient care and improved outcomes. The company was founded in 2019 and is based in Cambridge, Massachusetts.


Accellix develops fully automated, cost-effective, actionable cell-based analysis, 24/7 at the point of need, to a broad range of users. Its Accellix single-use cartridge analysis system provides results in less than 30 minutes, requires minimal training, and does not require users to deal with biological reagents, sample preparation, and complex data analysis.

EfA Technologies

EfA Technologies is the developer of RevDx, a portable device that can perform automated blood tests, diagnostics, and data analytics on the spot, a kind of hand-held hospital to assist under-equipped medical workers.

Cardea Bio

Cardea Bio is a mass producer of biocompatible semiconductors, also called the BPU™ (Biosignal Processing Unit). The BPU is a semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on the planet: nature and biology. Cardea Bio was founded in 2013 and is based in San Diego, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.